Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062394 · ClinicalTrials.gov registry record · NA
Penn Medicine Healthy Heart
A NA study of Hypertension and Hyperlipidemias, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 1,980
- Enrollment target
- 1
- Study location
NCT06062394: Recruiting NA study of Hypertension and Hyperlipidemias, sponsored by University of Pennsylvania.
NCT06062394 is a NA study of Hypertension and Hyperlipidemias that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,980 participants, below the 3,503-participant average among 470 other Hypertension trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062394, a NA study of Hypertension and Hyperlipidemias, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,980 participants
- Enrollment target
- 1
- Study location
Study Summary
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.
Primary Outcome
Whether mean SBP is improved among those assigned to intervention vs those assigned to control
Conditions Studied
Interventions
- BEHAVIORAL Penn Med Healthy Heart Program
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,980 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06062394 shows while recruiting
NCT06062394 is an interventional study that assigns participants to a tested intervention. Its 1,980 participants enrollment target places it among the larger protocols in the corpus, below the 3,503-participant average among 470 other Hypertension trials with a reported enrollment target (43% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Penn Med Healthy Heart Program is the first listed.
NCT06062394 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06062394 about?
NCT06062394 is a clinical study titled "Penn Medicine Healthy Heart". To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in imp...
What is the current status of trial NCT06062394?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,980 participants. The study started on 2024-03-11. Estimated completion is 2026-12.
What conditions does trial NCT06062394 study?
This clinical trial studies the following conditions: Hypertension, Hyperlipidemias.
What interventions are being tested in trial NCT06062394?
The interventions under investigation include: Penn Med Healthy Heart Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062394?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062394 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06062394's enrollment target sits among peer trials
1,980 40th of 470 higher than 431 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI